CCO Infectious Disease Podcast

Implementing Long-Acting Cabotegravir Plus Rilpivirine for HIV Treatment: System-Level Considerations

Episode Summary

This podcast episode features an international panel discussion on clinic-level considerations for incorporating long-acting ART into the HIV treatment paradigm.

Episode Notes

In this episode, an international expert panel shares their thoughts on key considerations at the operational level for incorporating long-acting injectable antiretroviral therapy into the HIV treatment armamentarium. Topics include the duration of injection appointments in real-world settings, managing additional patient volume/workload (particularly the key role of nurses), and preventing and addressing planned and unplanned missed doses. Other episodes in this 4-part series cover additional aspects of long-acting antiretrovirals for HIV treatment and prevention, including:

Presenters:

Babafemi Taiwo, MBBS
Gene Stollerman Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Yvonne Gilleece, MB, BCh, BAO
Honorary Clinical Professor in HIV Medicine and Sexual Health
Department of Global Health & HIV
Brighton & Sussex Medical School
Consultant in HIV Medicine and Sexual Health
HIV Department
University Hospitals Sussex NHS Foundation Trust
Brighton, United Kingdom  

Cristina Mussini, MD
Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases
Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Darrell H. S. Tan, MD, FRCPC, PhD
Associate Professor
Division of Infectious Diseases
University of Toronto
Clinician-Scientist
Division of Infectious Diseases
St. Michael's Hospital
Toronto, Canada

Content based on an online CME/CE program supported by an independent educational grant from ViiV Healthcare.  

Link to full program:
https://bit.ly/3P3uPBc